Drug comparisons
Acarbose vs Vildagliptin
Acarbose (Precose) vs Vildagliptin: Delays carb absorption vs DPP-4 inhibition for incretin boost. Oral T2DM drugs, no black box warnings.
No comparison dimensions are available for this page.
Clinical context
This comparison arises for patients with type 2 diabetes considering an alpha-glucosidase inhibitor versus a DPP-4 inhibitor for glycemic control.
Bottom line
Acarbose delays carbohydrate digestion for postprandial control with GI side effects while Vildagliptin inhibits DPP-4 offering glucose-dependent insulin release with fewer GI issues.
All medication comparisons